HOZAIR SYED: Open Payments
NPI 1235342098 · PISMO BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,885 in 235 payments from 16 companies in 2025. Trend: 2023 $1,508 · 2024 $3,803 · 2025 $4,885
Food & beverage: $4,662Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 45 | $1,042 |
| Neurocrine BioSciences, Inc. | 21 | $613 |
| Alkermes, Inc. | 23 | $594 |
| Otsuka America Pharmaceutical, Inc. | 25 | $483 |
| E.R. Squibb & Sons, L.L.C. | 25 | $479 |
| Janssen Pharmaceuticals, Inc | 25 | $424 |
| ABBVIE INC. | 21 | $329 |
| Axsome Therapeutics, Inc. | 15 | $317 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $282 |
| Lundbeck LLC | 10 | $171 |
Products named: INGREZZA, ARISTADA, UZEDY, COBENFY, REXULTI, VRAYLAR, AUSTEDO XR, Auvelity.
Industry payments across CA — which companies pay providers there.
